Cargando…

Messenger RNA Gene Expression Screening of VIP and PACAP Neuropeptides and Their Endogenous Receptors in Ruminants

SIMPLE SUMMARY: This study aimed to measure the neuropeptides, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP), and their receptors, termed VPAC1, VPAC2 and PAC1 in ruminants. To date, we are unaware of any reported quantitative polymerase chain rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawley, Emma, Mia, Kafi, Yusuf, Mustapha, Swanson, Kendall C., Doetkott, Curt, Dorsam, Glenn P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598725/ https://www.ncbi.nlm.nih.gov/pubmed/36290416 http://dx.doi.org/10.3390/biology11101512

Ejemplares similares

PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism
por: Vu, John P., et al.
Publicado: (2023)

Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP
por: Temerozo, Jairo R., et al.
Publicado: (2013)

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP
por: Liao, Chenyi, et al.
Publicado: (2021)

Signal Transduction by VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2022)

PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP
por: Bensalma, Souheyla, et al.
Publicado: (2019)

Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress—Relevance to Multiple Sclerosis Pathophysiology
por: Withana, Minduli, et al.
Publicado: (2023)

Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus
por: Lee, Jayden, et al.
Publicado: (2023)

Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2021)

Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet
por: Mandwie, Mawj, et al.
Publicado: (2021)

Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
por: Lu, Jessica, et al.
Publicado: (2022)

Female reproductive functions of the neuropeptide PACAP
por: Koppan, Miklos, et al.
Publicado: (2022)

Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
por: Schytz, Henrik Winther, et al.
Publicado: (2010)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
por: Deligianni, Christina, et al.
Publicado: (2023)

Adipose Tissue Expression of PACAP, VIP, and Their Receptors in Response to Cold Stress
por: Cline, Daemon L., et al.
Publicado: (2018)

Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System
por: Musumeci, Giuseppe, et al.
Publicado: (2018)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today's Highly Diversified Forms
por: Ng, Stephanie Y. L., et al.
Publicado: (2012)

PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
por: Broome, Sarah Thomas, et al.
Publicado: (2022)

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
por: Tanaka, Masaru, et al.
Publicado: (2023)

Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration
por: Woodley, Patricia K., et al.
Publicado: (2019)

The neuropeptide PACAP alleviates T. gondii infection-induced neuroinflammation and neuronal impairment
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2022)

Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
por: Jansen, Margo I., et al.
Publicado: (2022)

Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction
por: Yan, Xiang, et al.
Publicado: (2023)

Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
por: Broome, Sarah Thomas, et al.
Publicado: (2023)

Roles of Neuropeptides, VIP and AVP, in the Mammalian Central Circadian Clock
por: Ono, Daisuke, et al.
Publicado: (2021)

PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression
por: Maugeri, Grazia, et al.
Publicado: (2016)

Expression and significance of TIMP-3, PACAP and VIP in vaginal wall tissues of patients with stress urinary incontinence
por: Fan, Bo, et al.
Publicado: (2017)

Corrigendum: Roles of Neuropeptides, VIP and AVP, in the Mammalian Central Circadian Clock
por: Ono, Daisuke, et al.
Publicado: (2021)

The Protective Effects of Endogenous PACAP in Oxygen-Induced Retinopathy
por: Kvarik, Timea, et al.
Publicado: (2021)

PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models*
por: Anapindi, Krishna D.B., et al.
Publicado: (2019)

Neuropeptide immunofluorescence in human nasal mucosa: assessment of the technique for vasoactive intestinal peptide (VIP)
por: de Mendonça, Jeferson Cedaro, et al.
Publicado: (2015)

PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
por: Karunia, Jocelyn, et al.
Publicado: (2021)

Interferon-γ Produced by Microglia and the Neuropeptide PACAP Have Opposite Effects on the Viability of Neural Progenitor Cells
por: Mäkelä, Johanna, et al.
Publicado: (2010)

Immunoreactivity of NOS, CGRP, PACAP, SP and VIP in the trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 of the cat
por: Christiansen, Tove, et al.
Publicado: (2003)

The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney
por: Horvath, Gabriella, et al.
Publicado: (2019)

VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects
por: Sragovich, Shlomo, et al.
Publicado: (2020)

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits
por: Ciranna, Lucia, et al.
Publicado: (2021)

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis
por: Castro-Vazquez, David, et al.
Publicado: (2021)

Zinc messenger
por: Powell, Kendall
Publicado: (2007)

Expression Patterns of PACAP and PAC1R Genes and Anorexigenic Action of PACAP1 and PACAP2 in Zebrafish
por: Nakamachi, Tomoya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gfgsvs375v348ka4bc9tbsl5r1